Document is current
Any future updates will be listed below
-
Authors
Pellegrino, Raffaello https://orcid.org/0000-0001-5874-0376
Paganelli, Roberto https://orcid.org/0000-0003-3467-9317
Di Iorio, Angelo https://orcid.org/0000-0003-2899-146X
Candeloro, Matteo https://orcid.org/0000-0001-9673-4073
Volpato, Stefano https://orcid.org/0000-0003-4335-6034
Bandinelli, Stefania https://orcid.org/0000-0002-6491-0850
Moretti, Antimo https://orcid.org/0000-0002-4598-2891
Iolascon, Giovanni https://orcid.org/0000-0002-0976-925X
Tanaka, Toshiko https://orcid.org/0000-0002-4161-3829
Ferrucci, Luigi https://orcid.org/0000-0002-6273-1613
-
Funding
Funding for this research was provided by:
Ministero della Salute (ICS 110.1/RS97.71)
National Institute on Aging (N01-AG-916413)
National Institute on Aging (N01-AG-5-0002)
National Institute on Aging (N01-AG-821336)
National Institute on Aging (R01-AG-027012)
Università degli Studi G. D'Annunzio Chieti Pescara
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 17 January 2025
First Online: 30 January 2025
Declarations
:
: The InCHIANTI study baseline was approved by the ethical committee at INRCA, Ancona (protocol 14/CE, 28 February 2000), as the FU1 (protocol 45/01, 16 January 2001). InCHIANTI study FU2 and FU3 were approved by the Local Ethical Committee at Azienda Sanitaria Firenze (protocol no. 5/04, 12 May 2004). The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of INRCA di Ancona (Italy). Clinical Trial Registration: NCT01331512.
: Written informed consent was obtained from the patients to participate at the study.
: Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.
: The authors declare no competing interests.
